Literature DB >> 11257007

Structural analysis of the role of the beta 3 subunit of the alpha V beta 3 integrin in IGF-I signaling.

L A Maile1, J Badley-Clarke, D R Clemmons.   

Abstract

The disintegrin echistatin inhibits ligand occupancy of the alpha V beta 3 integrin and reduces Insulin-like growth factor I (IGF-I) stimulated migration, DNA synthesis, and receptor autophosphorylation in smooth muscle cells. This suggests that ligand occupancy of the alpha V beta 3 receptor is required for full activation of the IGF-I receptor. Transfection of the full-length beta 3 subunit into CHO cells that have no endogenous beta 3 and do not migrate in response to IGF-I was sufficient for IGF-I to stimulate migration of these anchorage dependent cells. In contrast, transfection of either of two truncated mutant forms of beta 3 (terminating at W(715) or E(731)) or a mutant with substitutions for Tyr(747) Tyr(759) (YY) into either CHO or into porcine smooth muscle cells did not restore the capacity of these cells to migrate across a surface in response to IGF-I. This effect was not due to loss of IGF-I receptor autophosphorylation since the response of the receptor to IGF-I was similar in cells expressing either the full-length or any of the mutant forms of the beta 3 subunit. Echistatin reduced IGF-I receptor phosphorylation in cells expressing the full-length or the YY mutant forms of beta 3 subunit, but it had no effect in cells expressing either of two truncated forms of beta 3. A cell-permeable peptide homologous to the C-terminal region of the beta 3 subunit (amino acids 747-762) reduced IGF-I stimulated migration and receptor autophosphorylation of non-transfected porcine smooth muscle cells. These results demonstrate that the full-length beta 3 with intact tyrosines at positions 747 and 759 is required for CHO cells to migrate in response to IGF-I. Furthermore, a region of critical amino acids between residues 742-762 is required for echistatin to induce its regulatory effect on receptor phosphorylation. Since the IGF-I receptor does not bind to alpha V beta 3 the results suggest that specific but distinct regions of the beta 3 subunit interact with intermediary proteins to facilitate IGF-I stimulated cell migration and echistatin induced inhibition of IGF-I signal transduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257007     DOI: 10.1242/jcs.114.7.1417

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  8 in total

1.  Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.

Authors:  Yan Ling; Laura A Maile; Jaroslava Lieskovska; Jane Badley-Clarke; David R Clemmons
Journal:  Mol Biol Cell       Date:  2005-05-11       Impact factor: 4.138

2.  Integrin expression regulates neuroblastoma attachment and migration.

Authors:  Amy Meyer; Cynthia M van Golen; Bhumsoo Kim; Kenneth L van Golen; Eva L Feldman
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

3.  Insulin-like growth factor (IGF) signaling requires αvβ3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation.

Authors:  Masaaki Fujita; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2012-12-14       Impact factor: 5.157

Review 4.  Integrin and growth factor receptor alliance in angiogenesis.

Authors:  Payaningal R Somanath; Alieta Ciocea; Tatiana V Byzova
Journal:  Cell Biochem Biophys       Date:  2008-12-02       Impact factor: 2.194

5.  Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the alphaVbeta3 integrin.

Authors:  Laura A Maile; Ariel W Aday; Walker H Busby; Ravi Sanghani; Umadevi Veluvolu; David R Clemmons
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

Review 6.  Integrins, insulin like growth factors, and the skeletal response to load.

Authors:  D D Bikle
Journal:  Osteoporos Int       Date:  2008-03-29       Impact factor: 4.507

7.  Blocking αVβ3 integrin ligand occupancy inhibits the progression of albuminuria in diabetic rats.

Authors:  Laura A Maile; Katherine Gollahon; Christine Wai; Paul Dunbar; Walker Busby; David Clemmons
Journal:  J Diabetes Res       Date:  2014-10-20       Impact factor: 4.011

8.  Anabolic effects of IGF-1 signaling on the skeleton.

Authors:  Candice G T Tahimic; Yongmei Wang; Daniel D Bikle
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-04       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.